Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB?
Kwok Chiu
KC
Chang
Chi Chiu
CC
Leung
Cheuk Ming
CM
Tam
Wing Wai
WW
Yew
D000995:Antitubercular Agents / Q000627:therapeutic use*; D054908:Extensively Drug-Resistant Tuberculosis / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000145:classification* / Q000188:drug therapy*
D000995:Antitubercular Agents; D015242:Ofloxacin; D013307:Streptomycin